Evolutionary Tree Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
66,869
-34,041
-34% -$959K 3.14% 16
2025
Q4
$3.17M Buy
100,910
+25,893
+35% +$859K 3.69% 10
2025
Q3
$2.68M Sell
75,017
-14
-0% -$639 2.92% 17
2025
Q2
$4.32M Buy
75,031
+1,164
+2% +$65.8K 4.59% 7
2025
Q1
$4.3M Buy
73,867
+12,749
+21% +$870K 5% 5
2024
Q4
$4.92M Sell
61,118
-8,725
-12% -$745K 5.01% 5
2024
Q3
$5.6M Buy
69,843
+3,604
+5% +$256K 5.6% 5
2024
Q2
$4.05M Buy
66,239
+16,352
+33% +$973K 4.16% 6
2024
Q1
$2.47M Buy
49,887
+781
+2% +$37.2K 2.48% 15
2023
Q4
$2.06M Buy
49,106
+46
+0.1% +$1.57K 2.27% 16
2023
Q3
$1.61M Buy
49,060
+7,712
+19% +$263K 2.08% 18
2023
Q2
$1.46M Buy
41,348
+6,953
+20% +$230K 1.76% 23
2023
Q1
$977K Buy
+34,395
New +$1.21M 1.35% 26

Other funds holding PRCT

Evolutionary Tree Capital Management's PRCT Position: Q1 2026 in Review

Evolutionary Tree Capital Management reduced its Procept Biorobotics (PRCT) stake by 34% in Q1 2026, selling an estimated $959K and leaving 66,869 shares worth $1.67M. The position accounts for 3.14% of the portfolio, ranked #16.

Evolutionary Tree Capital Management first reported a position in PRCT in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.6M in Q3 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Evolutionary Tree Capital Management held 66,869 shares of Procept Biorobotics worth $1.67M as of Q1 2026.
  • Evolutionary Tree Capital Management sold 34,041 Procept Biorobotics shares in Q1 2026, an estimated $959K.
  • Procept Biorobotics made up 3.14% of Evolutionary Tree Capital Management's portfolio in Q1 2026, its #16 holding.
  • Evolutionary Tree Capital Management first reported a position in Procept Biorobotics in Q1 2023 and has held it in 13 quarters since.
  • Evolutionary Tree Capital Management's Procept Biorobotics position peaked at $5.6M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2026, filed 22 May 2026.